CTLA4 and metastatic melanoma: Simultaneously, the stool was obtained from a group of 42 patients with metastatic melanoma treated with ICI (38 = anti-PD-1, 4 = anti-CTLA-4), and the GM was analysed using a combination of 16S rRNA sequencing and shotgun metagenomic sequencing.